Atara has just announced a CRL by FDA for EBVALLO. EBVALLO is already approved in Europe since December 2022 and the cause of the CRL seems minor and easily addressable. The CRL has a major impact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback